tirzepatide and carnivore Mounjaro (Tirzepatide): Raising the Bar for GLP-1 Treatments – Nutri-Align Tirzepatide & Semaglutide Weight Loss

Contraindications to MRI (metallic implants, pacemaker, severe claustrophobia)

Eder, L., Thavaneswaran, A., Chandran, V., Cook, R

Routine measurement of serum calcitonin levels or thyroid ultrasound screening before starting GLP-1 therapy is not recommended in asymptomatic patients without specific risk factors

Wegovy (semaglutide 2.4 mg) is a once-weekly injectable medication licensed in the UK for weight management in adults with obesity or those who are overweight with weight-related health conditions

Menopause, sleep disruption, vasomotor symptoms, insulin resistance, body-composition changes, thyroid dysfunction, low testosterone, and chronic stress signaling can all influence how patients feel, recover, move, sleep, and maintain metabolic health

Direct comparison meta-analysis When researchers pooled data from comparable studies, retatrutide produced an average of 16.34 kg of weight loss compared to 11.82 kg for tirzepatide